GeneBioTech Co. ,Ltd (KOSDAQ: 086060)

GeneBioTech Co. ,Ltd Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	29,836	37,542	34,356	45,119	49,511	48,391
Market Cap Growth	-6.83%	9.27%	-23.85%	-8.87%	2.31%	38.25%
Enterprise Value	22,374	30,940	31,105	35,590	41,859	37,286
Last Close Price	3465.00	4360.00	3990.00	5240.00	5716.70	5557.47
PE Ratio	12.29	14.49	22.55	-93.15	-21.02	56.51
PS Ratio	0.37	0.47	0.42	0.72	0.84	0.83
PB Ratio	0.60	0.78	0.75	1.03	0.98	1.12
P/FCF Ratio	16.82	5.49	-7.11	-7.76	-26.13	-9.78
P/OCF Ratio	16.46	5.09	-9.34	-16.63	19.87	-18.05
EV/Sales Ratio	0.28	0.39	0.38	0.57	0.71	0.64
EV/EBITDA Ratio	4.70	5.83	10.94	44.98	44.05	14.76
EV/EBIT Ratio	6.58	7.79	19.98	-78.54	-38.16	44.31
EV/FCF Ratio	12.61	4.52	-6.43	-6.12	-22.09	-7.54
Debt / Equity Ratio	0.32	0.26	0.28	0.23	0.11	0.40
Debt / EBITDA Ratio	3.34	2.35	4.58	13.02	5.90	6.86
Debt / FCF Ratio	8.97	1.83	-2.70	-1.77	-2.96	-3.50
Asset Turnover	1.17	1.22	1.33	1.03	0.91	0.83
Inventory Turnover	4.12	4.35	4.97	4.59	4.69	5.10
Quick Ratio	1.95	2.33	1.91	1.99	4.44	3.30
Current Ratio	2.93	3.40	2.91	2.98	5.92	4.41
Return on Equity (ROE)	5.03%	5.51%	3.40%	-1.03%	-0.13%	-0.06%
Return on Assets (ROA)	3.11%	3.82%	1.56%	-0.46%	-1.05%	0.75%
Return on Capital (ROIC)	3.36%	4.15%	1.72%	-0.51%	-1.17%	0.86%
Earnings Yield	8.14%	6.90%	4.43%	-1.07%	-4.73%	1.75%
FCF Yield	5.95%	18.22%	-14.07%	-12.89%	-3.83%	-10.23%
Dividend Yield	0.00%	-	-	-	0.52%	0.54%
Payout Ratio	0.00%	-	-	-	-	30.51%
Buyback Yield / Dilution	0.18%	-	-	-	-	-
Total Shareholder Return	0.18%	-	-	-	0.52%	0.54%

Source: S&P Capital IQ. Standard template. Financial Sources.